Latest from the Join Dementia Research service
ENRICHEnabling Research in Care Homes
POSTS
Latest from the Join Dementia Research service
The Join Dementia Research service now has 60,000 volunteers signed up to take part in research. This is really positive, but we always need more people to join us to help make research breakthroughs possible. So please encourage your residents and their families and friends to sign up for Join Dementia Research.
“The most exciting development for Alzheimer’s research in recent months has been the CLARITY-AD study results. CLARITY-AD has been investigating the drug lecanemab, which is the first drug to slow cognitive decline in people with early-stage Alzheimer’s disease.
Join Dementia Research volunteers helped to make these findings possible by taking part in the UK clinical trials. Regulatory approval is now being sought for the drug to be prescribed in the US and Europe.
Some of the many studies currently recruiting through Join Dementia Research include:
- A study investigating the impact of anti-inflammatory drugs on Alzheimer’s disease
- A NIHR-funded study looking at the benefits of singing for people with dementia
The Join Dementia Research service now has 60,000 volunteers signed up to take part in research. This is really positive, but we always need more people to join us to help make research breakthroughs possible. So please encourage your residents and their families and friends to sign up for Join Dementia Research.”